Section: Surgical Oncology Curriculum: Curriculum, page 73

General

  • Historically challenging
    • Stimulates a strong graft rejection response
      • Small intestine contains large amounts of lymphoid tissue
    • Ischaemia and rejection increase intestinal permeability
      • Allow translocation of bacteria from the lumen
    • Operation often complex
  • Graft rejection and infection remain major problems
    • Results obtained are inferior to those obtained after other types of organ transplantation

Indications

  • Indicated for intestinal failure requiring TPN
    • Short gut, or intestinal dysfunction caused by:
      • Intestinal atresia
      • Necrotising enterocolitis
      • Volvulus
      • Disorders of motility
      • Mesenteric infarction
      • Crohn’s disease
      • Trauma
      • Desmoid tumours
  • Indications
    • Recurrent line complications - sepsis or clots.
    • TPN associated liver failure (SB transplantation is combined with liver transplantation)
    • Frequent episodes of severe dehydration despite intravenous fluid administration in addition to parenteral nutrition

Technique

  • May be carried out as an isolated procedure (highest survival)
    • Performed together with a liver transplant
    • Or as a component of a multivisceral transplant
  • Deceased donor transplant
    • Comprises the entire small bowel
      • Not ascending colon
    • SMA of the graft (with an aortic patch) is anastomosed to the recipient aorta
    • SMV is anastomosed to the IVC or to the side of the Portal Vein
    • Proximal end of SB graft anastomosed to the recipient jejunum or duodenum
    • Distal end
      • Anastomosed to right colon (with loop ileostomy)
      • Or Direct end ileostomy
    • Draining gastrostomy and feeding jejunostomy inserted
  • ½ of patients on long-term TPN also require liver transplant due to cholestatic liver disease
    • Do both en-bloc

Implications of anastomosing SMV to IVC

  • Liver metabolism and detoxification is being bypassed
    • Results in increased ammonia
    • Changes to protein and lipid metabolism.
    • Increased risk of sepsis
    • Increased immune activation
      • Which can contribute to graft rejection.

Outcomes

  • 1-year graft survival rate 65% 2009 - latest data suggests up 90% at 1 year
    • For both isolate SB transplantation and for combined with liver
  • 3 years, the graft survival rate is around 45%
  • Survival better after isolated SB transplantation than after combined liver
    • Loss of the graft usually equates with death
  • Mortality due to sepsis and multi-organ failure
    • Risk of infection heightened by the additional requirements for immunosuppression to control graft rejection
    • Also accounts for the relatively high incidence of lymphoproliferative disease (10%)
  • Because of the large amount of donor lymphoid tissue transplanted, GVHD may be an added complication
  • Despite the hazards, small bowel transplantation offers pts with IF a chance to lead an active life, free from long-term nutritional support